INS and gestational diabetes: The FDA label also expresses worries about metformin-triggered lactic acidosis in liver failure, potentially due to hindered lactate clearance.(12) There is still debate regarding the therapeutic equivalence between metformin and insulin in the treatment of gestational diabetes mellitus.